Loading organizations...

§ Private Profile · Atlanta, GA, USA
OncoHealth is a technology company.
OncoHealth delivers a digital health platform for comprehensive oncology care management. It uses data analytics and technology to provide evidence-based solutions for health plans, providers, and patients. The platform addresses cancer treatment's physical, mental, and financial complexities, optimizing care and improving patient outcomes through streamlined coordination.
The company began as Oncology Analytics, founded in 2009 by Marc Fishman and Ed Krupski. Their insight identified a need for structured, data-driven cancer care, leading to technology solutions for efficiency and clarity. The organization rebranded to OncoHealth in 2021, reflecting its expanded scope and patient engagement.
OncoHealth partners with health plans and employers, also supporting oncologists and patients. Its platform enhances treatment adherence and utilization management through virtual care and expert guidance. The company’s vision is to alleviate cancer’s burdens, making personalized, high-quality oncology care accessible and manageable for all involved in treatment.
OncoHealth has raised $58.1M across 4 funding rounds.
OncoHealth has raised $58.1M in total across 4 funding rounds.
OncoHealth has raised $58.1M in total across 4 funding rounds.
OncoHealth's investors include Baird Capital, 125 Ventures, 14W, Audrey Capital, BBG Ventures, Bond, BoxGroup, Dragoneer Investment Group, F-Prime Capital Partners, Future Perfect Ventures, General Catalyst, GenNx360.
OncoHealth is a digital health company specializing in oncology, offering an integrated software and services platform for oncology value management, utilization management, and virtual cancer care.[1][2][4] It builds products like OneUM™ for streamlining prior authorizations and evidence-based treatment reviews, and Iris™ for 24/7 supportive care including oncology nursing, mental health, nutrition, and resource navigation.[2][3][5] Serving health plans, employers, providers, patients, and life science researchers—supporting over 8 million people in the US and Puerto Rico—OncoHealth solves key challenges in cancer care: ensuring appropriate treatments to cut costs, reducing administrative burdens, addressing physical/mental side effects, and improving access in underserved areas like counties without oncologists.[1][3][4][5] The company demonstrates strong growth, expanding from data analytics roots to telehealth innovations and partnerships with health plans.[3][5][6]
Founded in 2009 and based in Atlanta, Georgia, OncoHealth evolved from Oncology Analytics, a data analytics and technology-enabled services firm focused on evidence-based utilization management for cancer treatments.[1][6] It pioneered tools like the OneUM platform, which normalized clinical data (e.g., EMR notes, biomarkers) and used machine learning to support prior authorizations for 5 million members across all cancer types and therapies.[6] Pivotal moments include launching Iris™ in 2022 as a consumer-facing telehealth platform, partnering with health plans for personalized supportive care, and scaling to power the nation's first oncology-focused 50-state virtual medical group.[1][3] Leadership, including CEO Mr. Maack with expertise in healthcare scaling and CMO Andrew Norden, MD, has driven its shift toward comprehensive virtual care amid rising oncology complexities.[1][3]
OncoHealth rides the digital health wave in oncology, where rising cancer prevalence (32 million Americans in oncologist-scarce areas) meets demands for value-based care amid exploding therapy costs and complexity.[3][5][6] Its timing aligns with telehealth acceleration post-pandemic, AI-driven personalization, and payer shifts toward utilization management to curb 5-10x costlier inappropriate treatments.[2][6] Market forces like biomarker-driven precision medicine and real-world data needs favor its analytics edge, influencing the ecosystem by enabling health plans to optimize networks, reduce disparities, and integrate supportive care—positioning it as a bridge between payers, providers, and patients in a $200B+ US oncology market.[1][4][6]
OncoHealth is poised for expansion through deeper health plan integrations, Iris scaling to more members, and leveraging real-world data for life sciences amid AI advancements in oncology.[1][3][5] Trends like virtual care mandates, value-based reimbursement, and personalized medicine will propel growth, potentially evolving its influence via acquisitions or platform APIs for broader ecosystems. As a pure-play oncology leader, it stands to lower cancer's toll further, reinforcing its mission from day one: right care, right time, right cost.[2][4]
OncoHealth has raised $58.1M across 4 funding rounds. Most recently, it raised $28.0M Series C in May 2020.